World Journal of Acupuncture-Moxibustion is a premier academic publication focusing on the fields of acupuncture and moxibustion, providing a platform for cutting-edge research and advancements in complementary and alternative medicine. Published by KEAI PUBLISHING LTD, this journal serves an international audience, fostering scholarly dialogue on evidence-based practices, methodologies, and clinical outcomes. With a commendable designation of Q3 in the 2023 category of Complementary and Alternative Medicine, it ranks 74th out of 105 journals in the field based on Scopus metrics, reflecting its significant contribution to the discipline. Although it operates under a subscription model, the journal's commitment to advancing knowledge from 2012 to 2024 makes it an essential resource for researchers, practitioners, and students aiming to deepen their understanding of acupuncture and its applications. For those in pursuit of innovative healing techniques and holistic health, the World Journal of Acupuncture-Moxibustion stands as a vital forum for exploring the intersection of traditional practices and modern scientific inquiry.

Traditional Medicine Research is a pioneering journal dedicated to advancing the field of traditional medicine through impactful research and scholarly discourse. Published by TMR Publishing Group, this Open Access journal has been committed to enhancing the accessibility of invaluable research since 2016. With its ISSN 2413-3973, it provides a platform for researchers, professionals, and students to explore and disseminate knowledge pertaining to various aspects of traditional medicinal practices, herbal therapies, and integrative healthcare solutions. Positioned to bridge the gap between ancient wisdom and modern scientific inquiry, Traditional Medicine Research plays a crucial role in fostering a deeper understanding of therapeutic traditions and their applications in contemporary health contexts. Scholars and practitioners are encouraged to engage with the latest findings, share innovative methodologies, and contribute to a vibrant community focused on the evolution and validation of traditional medicine.

Integrative Cancer Therapies, published by SAGE Publications Inc, is a leading journal dedicated to advancing the multidisciplinary field of cancer treatment through complementary and alternative medicine. With an ISSN of 1534-7354 and an E-ISSN of 1552-695X, this journal has been pivotal in disseminating impactful research since its inception in 2002, establishing itself as a resource for practitioners, researchers, and academicians. As a distinguished publication categorized in the Q1 quartile for Complementary and Alternative Medicine and Q3 for Oncology, it positions itself within the top echelons of its field, as evidenced by its Scopus rankings - 25/105 in Complementary and Alternative Medicine and 178/404 in Oncology. The objective of Integrative Cancer Therapies is to provide a platform for innovative approaches and studies that explore integrative methodologies in cancer care, thereby enhancing therapeutic outcomes and promoting holistic treatment perspectives. Researchers and healthcare professionals who contribute to or follow this journal gain access to cutting-edge findings and diverse perspectives that drive the evolution of cancer therapy.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Journal of the Chinese Medical Association, published by LIPPINCOTT WILLIAMS & WILKINS, is a prominent peer-reviewed journal in the field of general medicine, specifically focused on advancements and research within the Chinese medical community. Established in 2003 and with a scope that spans diverse medical disciplines, this journal has positioned itself as a key resource for medical professionals, researchers, and academics interested in both clinical practices and health policy in Taiwan and the broader context of Asian medicine. With an impressive Scopus ranking of 69 out of 636 in the general medicine category and a notable percentile rank of 89th, the journal is recognized for its contributions to medical science. Although it does not currently provide open access options, it continues to maintain a robust presence through its high-quality publications and rigorous peer-review process aimed at fostering innovation and sharing critical insights across the medical field. Researchers and students alike will find this journal an invaluable platform for disseminating their findings and engaging with current medical discourse.

Journal of Traditional Chinese Medicine, with the ISSN 0255-2922 and E-ISSN 1577-7014, is a distinguished publication dedicated to exploring the rich heritage and contemporary applications of Chinese medicinal practices. Published by JOURNAL TRADITIONAL CHINESE MED in China, this journal contributes significantly to the field of Complementary and Alternative Medicine, holding a respectable Q2 ranking in this category according to the 2023 metrics, and a Q3 ranking in miscellaneous medicine. With its coverage spanning from 1996 to 2024, the journal aims to advance scholarly research and foster an understanding of traditional Chinese healing methodologies, blending ancient wisdom with modern healthcare paradigms. While currently not classified as Open Access, it provides critical insights and detailed analyses that are invaluable for researchers, healthcare professionals, and students interested in the intersection of tradition and innovation in medical practices.

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

Chinese Medicine is a distinguished open-access journal published by BMC, focusing on the advancement of knowledge and practice in the domain of complementary and alternative medicine. With the ISSN 1749-8546, this journal has established itself as an important resource for researchers, professionals, and students interested in the integration of traditional Chinese medicine with modern scientific practices. Since its inception in 2006, it has garnered a notable reputation, achieving a Q1 ranking in Complementary and Alternative Medicine and Q2 in Pharmacology for 2023, reflecting its high impact and relevance within the academic community. The journal's commitment to disseminating quality research is evident in its Scopus rankings, placing it in the top decile for medicine and pharmacology disciplines. Open access since its launch, Chinese Medicine promotes widespread accessibility and encourages collaborative scholarly efforts in investigating the efficacy and applications of traditional practices in contemporary healthcare. By fostering a platform for rigorous discourse and innovative research, this journal serves as an essential conduit for advancing the understanding of Chinese medicine's role in global health.

Explore - The Journal of Science and Healing is a reputable publication by Elsevier Science Inc, dedicated to advancing the fields of complementary and alternative medicine, chiropractic practices, and health professions. With an ISSN of 1550-8307 and E-ISSN of 1878-7541, this journal cultivates a dynamic platform for researchers, practitioners, and scholars to disseminate innovative findings, theoretical advancements, and clinical applications across a range of interdisciplinary studies. Covering a broad spectrum from 2005 to 2024, it holds esteemed rankings in notable categories such as Chiropractics (Q2), Complementary and Alternative Medicine (Q2), and Nursing (Q2), underscoring its commitment to quality scholarship and impactful research. While currently operating under a subscription model, the journal aims to foster discourse and collaboration within the health sciences community, ultimately contributing to enhanced patient care and wellness strategies. Explore offers invaluable insights for those at the forefront of science and healing, ensuring its role as a vital resource in shaping the future of these evolving fields.

Advances in Integrative Medicine is a prestigious academic journal published by Elsevier, dedicated to the field of Complementary and Alternative Medicine. With an ISSN of 2212-9588 and an E-ISSN of 2212-9596, this journal has gained recognition for its high-quality research contributions, achieving a commendable Q2 ranking in the 2023 category of Complementary and Alternative Medicine according to Scopus, placing it at #39/105 in its field with a 63rd percentile ranking. Since its inception in 2014, the journal has been committed to advancing the understanding of integrative medicine practices through rigorous peer-reviewed research, systematic reviews, and innovative methodologies. Although it does not offer open access options, it remains a vital resource for researchers, professionals, and students interested in the latest evidence-based approaches within this dynamic and evolving area of healthcare. Based in Australia, with operations located at RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Advances in Integrative Medicine continues to serve as a leading platform for scholarly discourse, fostering advancements that can enhance patient care and therapeutic outcomes.